Concord Medical Services Stock Performance
| CCM Stock | USD 4.77 0.08 1.65% |
On a scale of 0 to 100, Concord Medical holds a performance score of 5. The firm shows a Beta (market volatility) of 0.37, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Concord Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Concord Medical is expected to be smaller as well. Please check Concord Medical's sortino ratio, skewness, relative strength index, as well as the relationship between the potential upside and day median price , to make a quick decision on whether Concord Medical's price patterns will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Concord Medical Services are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Concord Medical displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (4.60) | Year To Date Return (26.05) | Ten Year Return (92.88) | All Time Return (94.28) |
Last Split Factor 1:10 | Dividend Date 2016-01-29 | Ex Dividend Date 2015-12-23 | Last Split Date 2024-07-30 |
1 | IRIS Business Services Limited Looks Just Right With A 25 percent Price Jump | 01/15/2025 |
2 | Asia Pacific Tech Services Market Fueled by Strong Demand for Managed and Cloud Services in Q4 ISG Index | 01/22/2025 |
3 | Therap Services Care Plan module Empowers Provider Agencies with Comprehensive, Person-Centered Care Documentation | 02/06/2025 |
4 | Q3 2025 PTC India Financial Services Ltd Earnings Call Transcript | 02/07/2025 |
5 | iShares SP Small-Cap 600 Value ETF Shares Acquired by Kestra Private Wealth Services LLC | 02/10/2025 |
6 | Second Round Of Assault Charges Against Concord Police Officer Dropped | 02/12/2025 |
7 | ChoiceOne Financial Services Receives Federal Reserve Approval for Merger with Fentura Financial Inc Date Set for Merger Pending Conditions Met | 02/13/2025 |
8 | Alliance Aviation Services First Half 2025 Earnings EPS AU0.18 | 02/14/2025 |
| Begin Period Cash Flow | 159.3 M |
Concord |
Concord Medical Relative Risk vs. Return Landscape
If you would invest 420.00 in Concord Medical Services on November 20, 2024 and sell it today you would earn a total of 57.00 from holding Concord Medical Services or generate 13.57% return on investment over 90 days. Concord Medical Services is generating 0.5249% of daily returns assuming volatility of 7.819% on return distribution over 90 days investment horizon. In other words, 69% of stocks are less volatile than Concord, and above 90% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Concord Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Concord Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Concord Medical Services, and traders can use it to determine the average amount a Concord Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0671
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CCM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.82 actual daily | 69 69% of assets are less volatile |
Expected Return
| 0.52 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Concord Medical is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Concord Medical by adding it to a well-diversified portfolio.
Concord Medical Fundamentals Growth
Concord Stock prices reflect investors' perceptions of the future prospects and financial health of Concord Medical, and Concord Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Concord Stock performance.
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.044 | ||||
| Profit Margin | (0.80) % | ||||
| Operating Margin | (0.90) % | ||||
| Current Valuation | 466.43 M | ||||
| Shares Outstanding | 2.82 M | ||||
| Price To Earning | (3.90) X | ||||
| Price To Book | 3.00 X | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 537.4 M | ||||
| Gross Profit | (80.78 M) | ||||
| EBITDA | (344.16 M) | ||||
| Net Income | (297.66 M) | ||||
| Cash And Equivalents | 157.39 M | ||||
| Cash Per Share | 1.72 X | ||||
| Total Debt | 3.3 B | ||||
| Debt To Equity | 1.25 % | ||||
| Current Ratio | 0.71 X | ||||
| Book Value Per Share | (489.59) X | ||||
| Cash Flow From Operations | (276.47 M) | ||||
| Earnings Per Share | (11.86) X | ||||
| Market Capitalization | 20.71 M | ||||
| Total Asset | 6.05 B | ||||
| Retained Earnings | (4.06 B) | ||||
| Working Capital | (1.33 B) | ||||
| Current Asset | 1.51 B | ||||
| Current Liabilities | 1.51 B | ||||
About Concord Medical Performance
By examining Concord Medical's fundamental ratios, stakeholders can obtain critical insights into Concord Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Concord Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 27.58 | 26.20 | |
| Return On Tangible Assets | (0.07) | (0.06) | |
| Return On Capital Employed | (0.13) | (0.12) | |
| Return On Assets | (0.06) | (0.05) | |
| Return On Equity | 0.13 | 0.14 |
Things to note about Concord Medical Services performance evaluation
Checking the ongoing alerts about Concord Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Concord Medical Services help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Concord Medical is way too risky over 90 days horizon | |
| Concord Medical appears to be risky and price may revert if volatility continues | |
| Concord Medical has high likelihood to experience some financial distress in the next 2 years | |
| Concord Medical Services has 3.3 B in debt with debt to equity (D/E) ratio of 1.25, which is OK given its current industry classification. Concord Medical Services has a current ratio of 0.7, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Concord to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 537.4 M. Reported Net Loss for the year was (297.66 M) with loss before taxes, overhead, and interest of (80.78 M). | |
| Concord Medical Services has about 157.39 M in cash with (276.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72. | |
| Concord Medical has a frail financial position based on the latest SEC disclosures | |
| Roughly 18.0% of Concord Medical shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Alliance Aviation Services First Half 2025 Earnings EPS AU0.18 |
- Analyzing Concord Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Concord Medical's stock is overvalued or undervalued compared to its peers.
- Examining Concord Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Concord Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Concord Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Concord Medical's stock. These opinions can provide insight into Concord Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.86) | Revenue Per Share | Quarterly Revenue Growth (0.23) | Return On Assets | Return On Equity |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.